Message from the Company

At Neurocentrx, we know how challenging it can be to live with depression or bipolar disorder—especially when treatments haven’t worked. Our mission is to create new options that are grounded in science, guided by safety, and built to address real-world needs.

We are currently developing and studying a new investigational treatment based on oral ketamine, combined with digital tools to help ensure safe prescription management and care. This treatment is an investigational care approach still under research in clinical trials—it has not been approved by any regulatory agency and is not available by prescription.

Our company maintains resources for patients and providers interested in participating in clinical research. Please contact your provider to help address questions and consider options for your care.

We are working toward a future where better, more accessible care can be part of the path forward.

More information about upcoming clinical trials and participation will be available here soon.